How does drug resistance to targeted therapy occur?

Sixteen pumpkins on display in the Rad Onc lobby leading up to Halloween.

Iowa researchers explore gas-entrapping materials to boost chemotherapy, radiation treatments.

James Byrne, MD, PhD, assistant professor of radiation oncology at University of Iowa Health Care, has been awarded the prestigious 2024 NIH Director’s New Innovator Award, recognizing his groundbreaking work aimed at improving outcomes and quality of life for cancer patients undergoing radiation therapy. Byrne is one of 40 early career scientists across the nation to receive this award, which is part of the NIH Common Fund's High-Risk, High-Reward Research Program that supports exceptionally innovative research projects led by early career investigators.

A paper authored by Dr. Byrne has earned a place on the College of Medicine's Wall of Scholarship.

Richard Hakes, features the decorated face masks made for pediatric patients based on his experience as a H&N cancer patient.

An article published in Frontiers in Oncology discusses ways of reducing tumor motion for the treatment of pancreatic tumors.

Surrogate gating strategies used to treat moving targets.

A simple, yet accurate, methodology for the PSQA measurement.

Fresh ideas at annual meeting.

Carryn Anderson MD, is one of 48 Radiation Oncologists selected this year as an ASTRO Fellow.

Jessica Williams RN BSN OCN, was presented with the New Silver Level Professional Recognition Program (PRP) Award on April 2.

James Byrne is one of 11 faculty and staff recognized.

Comprehensive Motion Management upgrade to MR-Linac.